×
About 15,915 results

ALLMedicine™ Anxiety Disorders Center

Research & Reviews  5,277 results

Effects of Curcumin on Depression and Anxiety: A Narrative Review of the Recent Clinica...
https://doi.org/10.1007/978-3-030-56153-6_17 10.1177/070674371305801203 10.1017/S0033291709992261 10.1093/ije/dyu038 10.1097/00043764-200103000-00009 10.1186/1471-244X-12-120 10.1017/S2045796018000227 10.1017/S0033291717003622 10.1038/sj.npp.1301241 10.1002/ptr.5025 10.4088/JCP.v58n0603 10.1002/hup.918 10.1097/jcp.0b013e31815152a5 10.1126/scitranslmed.3004873 10.1177/153331750602100211 10.2174/092986710790149738 10.1016/j.mehy.2013.02.001 10.1016/j.mehy.2013.02.001 10.1002/jcp.25778 10.1080/10408398.2017.1358139 10.2174/1381612822666160527113501 10.1002/biof.1062 10.1016/0049-3848(85)90276-2 10.2337/dc12-0116 10.1002/ptr.5211 10.1186/1472-6882-6-10 10.1177/0269881116686883 10.1177/0269881112458732 10.1097/WNF.0000000000000344 10.1097/jcp.0b013e318160862c 10.1097/JCP.0000000000000508 10.1016/j.intimp.2018.12.012 10.4314/tjpr.v18i3.23 10.1038/s41386-018-0295-2 10.1007/s12640-017-9860-4 10.1016/j.jad.2016.09.047 10.1016/j.euroneuro.2014.11.015 10.1097/JCP.0000000000000352 10.1016/j.jad.2014.06.001 10.1097/WNF.0b013e31828ef969 10.1002/ptr.6571 10.1007/s00580-017-2624-y 10.14499/indonesianjpharm28iss3pp185 10.1007/s11655-015-2160-z 10.1002/da.22987 10.1089/ars.2007.1769 10.2174/138945011794815356 10.1111/j.1471-4159.2011.07356.x 10.1016/j.brainres.2007.05.071 10.1007/s00213-008-1300-y 10.1016/j.tips.2003.09.011 10.1016/j.npep.2009.12.014 10.1007/s00726-006-0335-9 10.1017/S0007114511006544 10.1152/ajpheart.01318.2007 10.1097/00000441-199403000-00011 10.1016/S0006-2952(99)00206-3 10.1176/ajp.144.2.263-a 10.1016/j.psychres.2012.09.032 10.1007/s12529-011-9190-5 10.1097/PSY.0b013e3181fdfb25 10.1097/PSY.0b013e31821a196f 10.1016/j.coph.2007.10.010 10.1016/j.lfs.2013.09.014 10.1016/j.jnutbio.2013.09.013 10.1016/j.pnpbp.2010.02.028 10.1016/j.phymed.2008.02.003 10.1016/j.brainres.2010.07.007 10.1016/j.biopsych.2009.03.012
Advances in Experimental Medicine and Biology; Khodadadegan MA, Azami S et. al.

Aug 1st, 2021 - Depressive and anxiety disorders affect a significant proportion of the global population and constitute one of the highest disease burdens worldwide. Conventional pharmacological treatments are traditionally the first line of therapy for individu...

Anxiety and depressive symptoms in U.S. Census Bureau assessments of adults: Trends fro...
https://doi.org/10.1016/j.janxdis.2021.102455
Journal of Anxiety Disorders; Twenge JM, McAllister C et. al.

Aug 1st, 2021 - Events from spring to fall 2020, including the COVID-19 pandemic, hate crimes, and social unrest, may have impacted mental health, particularly mood and anxiety disorders. This study compares rates of positive screens for anxiety and depressive di...

The association between the renin-angiotensin system and the hypothalamic-pituitary-adr...
https://doi.org/10.1016/j.psyneuen.2021.105354
Psychoneuroendocrinology Balthazar L, Lages YVM et. al.

Jul 31st, 2021 - Anxiety is characterized as the emotional response in anticipation of a future threat. This hypervigilant state comprehends a cascade of neuroendocrine and physiological processes, involving the renin-angiotensin system (RAS) and hypothalamic-pitu...

Managing rumination and worry: A pilot study of an internet intervention targeting repe...
https://doi.org/10.1016/j.jad.2021.07.076
Journal of Affective Disorders; Joubert AE, Grierson AB et. al.

Jul 31st, 2021 - Rumination and worry, both forms of repetitive negative thinking (RNT), have been implicated in the onset, maintenance, severity, and relapse risk of depression and anxiety disorders. Despite promising initial findings for internet-delivered inter...

Co-occurring attention-deficit/hyperactivity disorder and anxiety disorders differentia...
https://doi.org/10.1080/13854046.2021.1942554
The Clinical Neuropsychologist; Wodka EL, Parish-Morris J et. al.

Jul 29th, 2021 - To examine overlap and divergence of symptomatology in Autism Spectrum Disorder (ASD) with and without co-occurring Attention/Deficit Hyperactivity Disorder (ADHD) and/or Anxiety Disorder by age and sex. Participants included 25,078 individuals re...

see more →

Guidelines  8 results

Perinatal Mood and Anxiety Disorders: Research and Implications for Nursing Care.
https://doi.org/10.1016/j.jogn.2021.02.007
Journal of Obstetric, Gynecologic, and Neonatal Nursing :... Beck CT

Jun 9th, 2021 - Perinatal Mood and Anxiety Disorders: Research and Implications for Nursing Care.|2021|Beck CT,|

Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescent...
https://doi.org/10.1016/j.jaac.2020.05.005
Journal of the American Academy of Child and Adolescent P... Walter HJ, Bukstein OG et. al.

May 23rd, 2020 - Anxiety disorders are among the most common psychiatric disorders in children and adolescents. As reviewed in this guideline, both cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitor (SSRI) medication have considerable em...

Clinical Updates in Women's Health Care Summary: Mood and Anxiety Disorders: Primary an...
https://doi.org/10.1097/AOG.0000000000002295
Obstetrics and Gynecology; Osborne LM, Payne JL

Aug 24th, 2017 - The management of psychiatric disorders in women is complicated by reproductive life cycle events. Psychiatric disorders can be initiated or exacerbated during times of hormonal change (such as menarche, the premenstrual period, the postpartum per...

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512908
Clinical Pharmacology and Therapeutics; Hicks JK, Bishop JR et. al.

May 15th, 2015 - Selective serotonin reuptake inhibitors (SSRIs) are primary treatment options for major depressive and anxiety disorders. CYP2D6 and CYP2C19 polymorphisms can influence the metabolism of SSRIs, thereby affecting drug efficacy and safety. We summar...

Evidence-based guideline: assessment and management of psychiatric disorders in individ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897434
Neurology Minden SL, Feinstein A et. al.

Jan 1st, 2014 - To make evidence-based recommendations for screening, diagnosing, and treating psychiatric disorders in individuals with multiple sclerosis (MS). We reviewed the literature (1950 to August 2011) and evaluated the available evidence. Clinicians may...

see more →

Drugs  440 results see all →

Clinicaltrials.gov  228 results

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
https://clinicaltrials.gov/ct2/show/NCT00024635

May 8th, 2020 - The purpose of this protocol is to allow for the careful screening of patients and healthy volunteers for participation in research protocols in the Experimental Therapeutics and Pathophysiology Lab (ETPB) at the National Institute of Mental Healt...

Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
https://clinicaltrials.gov/ct2/show/NCT00397111

May 6th, 2020 - Objective A major component of understanding the pathogenesis of mood and anxiety disorders is expected to involve elucidation of abnormalities in brain structure and function associated with these conditions. Historically post-mortem histopatholo...

Mood Lifters: A Self Help Program
https://clinicaltrials.gov/ct2/show/NCT02558075

May 4th, 2020 - Approximately half the population of the United States will meet criteria for a diagnosable mental illness over their lifetime. Many of these individuals will experience changes in productivity, family relationships and self-esteem. Some will enga...

The Psychobiology of Childhood Temperament
https://clinicaltrials.gov/ct2/show/NCT00060775

Apr 30th, 2020 - Objectives: The goal of this proposal is to study temperament and risk-taking as vulnerability factors for anxiety. Studies have documented that behaviorally inhibited (BI) children are at risk for anxiety disorders. This vulnerability may be asso...

Expectation of Unpleasant Events in Anxiety Disorders
https://clinicaltrials.gov/ct2/show/NCT00055224

Apr 27th, 2020 - High-generalized anxiety is a concomitant of many anxiety disorders and is often regarded as a vulnerability marker for these disorders. One characteristic of patients with anxiety disorders and high trait-anxious individuals is inappropriate expe...

see more →

News  387 results

Insomnia in Kids Tied to Mood, Anxiety Disorders in Adulthood
https://www.medscape.com/viewarticle/953149

Jun 15th, 2021 - Insomnia in childhood persists into adulthood and may raise the risk for internalizing disorders in young adults, new research indicates. However, insomnia symptoms in childhood that remit in the transition to adolescence do not confer increased r...

Adult Separation Anxiety Raises Suicidality Risk
https://www.medscape.com/viewarticle/949020

Apr 8th, 2021 - Separation anxiety plays a substantial role in suicidality in patients with mood and anxiety disorders, new research suggests. Results of a study that included 500 outpatients with mood or anxiety disorders showed adult separation anxiety disorder...

Five-Minute Screen in Toddlers Predicts Subsequent Anxiety
https://www.medscape.com/viewarticle/948364

Mar 30th, 2021 - A five-minute, easy-to-administer screen in toddlers accurately predicts subsequent anxiety, providing an opportunity for early intervention to head off this potentially debilitating disorder. Investigators found the Fear and Shyness scales of the...

Erectile Dysfunction Prevalence High in Patients with Anxiety Disorders
https://www.medscape.com/viewarticle/946842

Mar 4th, 2021 - Takeaway This review found a high prevalence of erectile dysfunction (ED) in the anxiety disorder population and evidence that suggest ED may be more severe in this population. However, the evidence was limited because of the high heterogeneity be...

Opioid Prescribing for High-Risk Patients Continues to Rise
https://www.medscape.com/viewarticle/942287

Dec 9th, 2020 - Since the publication of the Centers for Disease Control and Prevention's (CDC's) opioid guideline in March 2016, there has been a substantial drop in the prescription rate for these medications ― except for patients at highest risk for opioid abu...

see more →

Patient Education  26 results see all →